Skip to main content
Arthur Kim, MD, Infectious Disease, Boston, MA, Massachusetts General Hospital

ArthurYu ShinKimMD

Infectious Disease Boston, MA

Assistant Professor of Medicine, Massachusetts General Hospital

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kim's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2000 - 2003
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1997 - 2000
  • Harvard Medical School
    Harvard Medical SchoolClass of 1997

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2002 - 2024
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy of Tocilizumab in Patients Hospitalized with Covid-19  
    Naomi J Serling-Boyd, Ann E Woolley, Manish Sagar, Harry Schrager, David S Huckins, Jorge Fleisher, Rachel S Wallwork, Arthur Y Kim, Pritha Sen, Eric Meyerowitz, Megan..., The New England Journal of Medicine
  • Efficacy of Tocilizumab in Patients Hospitalized with Covid-19  
    Naomi J Serling-Boyd, Ann E Woolley, Manish Sagar, Harry Schrager, Jorge Fleisher, Rachel S Wallwork, Arthur Y Kim, Pritha Sen, Eric Meyerowitz, Megan M Lockwood, Mich..., The New England Journal of Medicine
  • Efficacy of Tocilizumab in Patients Hospitalized with Covid-19  
    Naomi J Serling-Boyd, Ann E Woolley, Manish Sagar, Harry Schrager, Jorge Fleisher, Rachel S Wallwork, Arthur Y Kim, Pritha Sen, Eric Meyerowitz, Megan M Lockwood, Mich..., The New England Journal of Medicine
  • Join now to see all

Authored Content

  • Management of Hepatitis A in 2020-2021July 2020

Press Mentions

  • We Have a Cure for Hepatitis C. Why Are Hundreds of New Englanders Still Dying Every Year?
    We Have a Cure for Hepatitis C. Why Are Hundreds of New Englanders Still Dying Every Year?November 29th, 2022
  • The Monoclonal Antibodies Strike Back: New Data on Their Use in COVID-19
    The Monoclonal Antibodies Strike Back: New Data on Their Use in COVID-19September 14th, 2021
  • 7 Lessons We've Learned from This Pandemic to Remember for the Next One
    7 Lessons We've Learned from This Pandemic to Remember for the Next OneJune 11th, 2021
  • Join now to see all

Grant Support

  • Discovery And Assessment Of Genetic Determinants Of HCV And HIV ControlNational Institute On Drug Abuse2011
  • Acute HCV In The Prison PopulationNational Institute Of Allergy And Infectious Diseases2010–2011
  • Discovery And Assessment Of Genetic Determinants Of HCV And HIV ControlNational Institute Of Allergy And Infectious Diseases2010
  • Acute Hepatitis C Virus Infection In The Prison PopulationNational Institute Of Allergy And Infectious Diseases2007–2009
  • Cell Mediated Immunity To HCV In HIV+ PersonsNational Institute Of Allergy And Infectious Diseases2003–2007
  • Acute HCV Infection In The Prison PopulationNational Institute Of Allergy And Infectious Diseases2005–2006
  • Cell-Mediated Immunity To HCV In HIV+ PersonsNational Institute Of Allergy And Infectious Diseases2004–2006

Professional Memberships

Hospital Affiliations